Heart Failure

Showing NaN - NaN of 92

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Randomized Ablation-based AF Rhythm-control Versus Rate-control

Not yet recruiting
  • Atrial Fibrillation
  • Heart Failure
    • Porto Alegre, Brazil
    • +17 more
    Apr 6, 2022

    The Product Surveillance Registry REVERSE Post Approval Study

    Active, not recruiting
    • Heart Failure
      • Birmingham, Alabama
      • +122 more
      Feb 4, 2022

      Heart Failure Trial in Montréal (Cognitive training, Usual Care)

      Not yet recruiting
      • Heart Failure
      • Cognitive training
      • Usual Care
      • Montréal, Quebec, Canada
      • +1 more
      Jan 31, 2022

      Attain Performa™ Left Ventricular Quadripolar Leads Chronic

      Completed
      • Heart Failure
        • Birmingham, Alabama
        • +99 more
        Jan 28, 2022

        Heart Failure, Myocardial Infarction Trial in Canada, Puerto Rico, United States (High Dose Trivalent Influenza Vaccine,

        Completed
        • Heart Failure
        • Myocardial Infarction
        • High Dose Trivalent Influenza Vaccine
        • Standard Dose Quadrivalent Influenza Vaccine
        • Birmingham, Alabama
        • +189 more
        Dec 22, 2021

        Heart Failure, Iron-deficiency Trial in Worldwide (Ferric Carboxymaltose, Placebo)

        Active, not recruiting
        • Heart Failure
        • Iron-deficiency
        • Ferric Carboxymaltose
        • Placebo
        • Alexander City, Alabama
        • +345 more
        Nov 12, 2021

        Heart Failure Trial in Worldwide (Omecamtiv Mecarbil, Placebo, Standard of Care)

        Completed
        • Heart Failure
        • Omecamtiv Mecarbil
        • +2 more
        • Birmingham, Alabama
        • +1033 more
        Nov 2, 2021

        Heart Failure Trial in Worldwide (MPP)

        Terminated
        • Heart Failure
        • MPP
        • Huntsville, Alabama
        • +205 more
        Oct 28, 2021

        Heart Failure, Anemia, Cardiovascular Disease Trial in Worldwide (Darbepoetin alfa, Placebo)

        Completed
        • Heart Failure
        • +4 more
        • Darbepoetin alfa
        • Placebo
        • Birmingham, Alabama
        • +753 more
        Oct 31, 2021

        Heart Failure, Atrial Fibrillation Trial in Worldwide (Rhythm control, Rate Control)

        Completed
        • Heart Failure
        • Atrial Fibrillation
        • Rhythm control
        • Rate Control
        • Porto Alegre, Rio Grande Do Sul, Brazil
        • +20 more
        Oct 13, 2021

        Cardiac Mechanics, Biomarkers and Frailty in Aortic Stenosis

        Recruiting
        • Heart Failure
        • Aortic Stenosis
        • Observational only
        • Montreal, Quebec, Canada
          Montreal Heart Institute
        Aug 30, 2021

        Heart Failure Trial in Worldwide (Placebo, Omecamtiv mecarbil)

        Completed
        • Heart Failure
        • Placebo
        • Omecamtiv mecarbil
        • Mobile, Alabama
        • +149 more
        Jul 25, 2021

        Sleep Apnea, Heart Failure Trial in Worldwide (Adaptive Servo Ventilation)

        Terminated
        • Sleep Apnea
        • Heart Failure
        • Adaptive Servo Ventilation
        • Tucson, Arizona
        • +48 more
        Jul 9, 2021

        Heart Failure Trial in Vancouver, Toronto, Montreal (eCounseling + Usual Care)

        Completed
        • Heart Failure
        • eCounseling + Usual Care
        • Vancouver, British Columbia, Canada
        • +2 more
        Jun 30, 2021

        Heart Failure Trial in Worldwide (Finerenone (BAY94-8862), Placebo, Inspra (eplerenone))

        Completed
        • Heart Failure
        • Finerenone (BAY94-8862)
        • +2 more
        • Birmingham, Alabama
        • +171 more
        Jul 2, 2021

        Heart Failure Trial in Worldwide (Sodium Zirconium Cyclosilicate, Placebo)

        Terminated
        • Heart Failure
        • Sodium Zirconium Cyclosilicate
        • Placebo
        • National City, California
        • +75 more
        May 20, 2021

        Heart Failure Trial in Worldwide (Empagliflozin, Placebo)

        Completed
        • Heart Failure
        • La Mesa, California
        • +519 more
        Apr 26, 2021

        Heart Failure, Motivation Trial in Montreal (SIGN@L-A, SIGN@L-B)

        Completed
        • Heart Failure
        • Motivation
        • SIGN@L-A
        • SIGN@L-B
        • Montreal, Quebec, Canada
          Université de Montréal
        Apr 26, 2021

        Heart Failure Trial in Worldwide (Vericiguat (BAY1021189) (1.25 mg), Vericiguat (BAY1021189) (5 mg), Placebo)

        Completed
        • Heart Failure
        • Vericiguat (BAY1021189) (1.25 mg)
        • +2 more
        • Fountain Valley, California
        • +156 more
        Mar 2, 2021

        Heart Failure Trial in Worldwide (Vericiguat (BAY1021189) (1.25 mg), Vericiguat (BAY1021189) (5 mg), Placebo)

        Completed
        • Heart Failure
        • Vericiguat (BAY1021189) (1.25 mg)
        • +2 more
        • Fountain Valley, California
        • +157 more
        Feb 25, 2021

        Heart Failure Trial in Worldwide (Cardiac Resynchronization Therapy - MPP)

        Completed
        • Heart Failure
        • Cardiac Resynchronization Therapy - MPP
        • Birmingham, Alabama
        • +77 more
        Feb 15, 2021

        Model 4396 Left Ventricular (LV) Lead Chronic Performance Study

        Completed
        • Heart Failure
          • Gilbert, Arizona
          • +51 more
          Feb 15, 2021

          Optisure Lead Post Approval Study

          Terminated
          • Heart Failure
          • Tachycardia, Ventricular
          • St. Jude Medical Optisure Lead
          • Birmingham, Alabama
          • +59 more
          Jan 13, 2021

          Heart Failure Trial in Worldwide (Eplerenone)

          Completed
          • Heart Failure
          • Phoenix, Arizona
          • +307 more
          Dec 19, 2020

          Sodium-glucose Cotransporter 2 Inhibitors and Risk of

          Completed
          • Type2 Diabetes
          • +5 more
          • Sodium-glucose cotransporter 2 (SGLT2) inhibitors
          • Dipeptidyl peptidase-4 (DPP-4) inhibitors
          • Montreal, Quebec, Canada
            Lady Davis Institute for Medical Research, Jewish General Hospit
          Oct 1, 2020